Beranda › Leukemia Mieloid Akut › New Jersey › Newark
Uji klinis Leukemia Mieloid Akut di Newark, NJ
12 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Newark (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Morristown Medical Center, Morristown · 17 mi jauhnya
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi jauhnya
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- Newark Beth Israel Medical Center, Newark
- Morristown Medical Center, Morristown · 17 mi jauhnya
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Menerima pesertaFase 1/2
- Atlantic Health, Morristown · 17 mi jauhnya
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Morristown Medical Center, Morristown · 17 mi jauhnya
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Menerima pesertaFase 3
- Morristown Medical Center, Morristown · 17 mi jauhnya
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Menerima pesertaFase 2/3
- Atlantic Health, Morristown · 17 mi jauhnya
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Menerima pesertaFase 1/2
- Atlantic Health, Morristown · 17 mi jauhnya
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Studi lain di Newark
- Kanker Payudara18 studi
- Cedera Sumsum Tulang Belakang13 studi
- Kanker Paru Non-Sel Kecil13 studi
- Gagal Jantung10 studi
- Kanker Metastatik10 studi
- Penyakit Kardiovaskular9 studi
- Kanker Pankreas9 studi
- Melanoma8 studi
- Kanker (semua jenis)7 studi
- Kanker Paru7 studi
- Penyakit Crohn7 studi
- Stenosis Katup Aorta6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.